BURLESON GENE E 4

What Happened

• Gene E. Burleson, a director of Regional Health Properties, Inc. (RHEP), received a grant of 3,000 non‑qualified stock options on January 16, 2026. The Form 4 reports the acquisition as an award (transaction code A) with an instrument value recorded as $0.00 on the filing.

Key Details

• Transaction date: 2026-01-16 (reported on Form 4 filed 2026-02-09).
• Grant: 3,000 non‑qualified stock options under the company’s Amended and Restated 2023 Omnibus Incentive Compensation Plan (footnote F1).
• Reported price/value: $0.00 on the Form 4; filing notes that the market reference was the average of the OTC high/low on Jan 16, 2026 (footnote F2).
• Vesting: Options vest immediately (footnote F3).
• Shares owned after transaction: Not specified in the Form 4 (not disclosed in the reported transaction).
• Timeliness: The Form 4 was filed on Feb 9 for a Jan 16 grant—this is later than the typical 2‑business‑day reporting window, so the filing appears late.

Context

• These are option awards (a derivative grant), not an outright stock purchase or sale. Immediate vesting means the options are exercisable right away, but the filing does not indicate any exercise or sale of underlying shares. Such awards are commonly used as compensation for directors; they do not by themselves signal a purchase of shares on the open market.